These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Ropinirole: a review of its use in the management of Parkinson's disease. Matheson AJ; Spencer CM Drugs; 2000 Jul; 60(1):115-37. PubMed ID: 10929932 [TBL] [Abstract][Full Text] [Related]
64. Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients. Kumar R; Hauser RA; Mostillo J; Dronamraju N; Graf A; Merschhemke M; Kenney C Int J Neurosci; 2016; 126(1):20-4. PubMed ID: 24007304 [TBL] [Abstract][Full Text] [Related]
65. Rasagiline improves quality of life in patients with early Parkinson's disease. Biglan KM; Schwid S; Eberly S; Blindauer K; Fahn S; Goren T; Kieburtz K; Oakes D; Plumb S; Siderowf A; Stern M; Shoulson I; Mov Disord; 2006 May; 21(5):616-23. PubMed ID: 16450340 [TBL] [Abstract][Full Text] [Related]
66. Rasagiline as Adjunct to Levodopa for Treatment of Parkinson's Disease: A Systematic Review and Meta-Analysis. Kano O; Tsuda H; Hayashi A; Arai M Parkinsons Dis; 2022; 2022():4216452. PubMed ID: 36081594 [TBL] [Abstract][Full Text] [Related]
67. Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group. Block G; Liss C; Reines S; Irr J; Nibbelink D Eur Neurol; 1997; 37(1):23-7. PubMed ID: 9018028 [TBL] [Abstract][Full Text] [Related]
68. Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa. Marsden CD Drugs; 1998; 55 Suppl 1():17-22. PubMed ID: 9483166 [TBL] [Abstract][Full Text] [Related]
70. Rasagiline for dysexecutive symptoms during wearing-off in Parkinson's disease: a pilot study. Rinaldi D; Assogna F; Sforza M; Tagliente S; Pontieri FE Neurol Sci; 2018 Jan; 39(1):141-143. PubMed ID: 28956175 [TBL] [Abstract][Full Text] [Related]
71. Effects of rasagiline on freezing of gait in Parkinson's disease - an open-label, multicenter study. Cibulcik F; Benetin J; Kurca E; Grofik M; Dvorak M; Richter D; Donath V; Kothaj J; Minar M; Valkovic P Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):549-552. PubMed ID: 27108605 [TBL] [Abstract][Full Text] [Related]
72. Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease. Olanow CW; Kieburtz K; Stern M; Watts R; Langston JW; Guarnieri M; Hubble J; Arch Neurol; 2004 Oct; 61(10):1563-8. PubMed ID: 15477510 [TBL] [Abstract][Full Text] [Related]
73. Comparison of pramipexole and levodopa/benserazide combination therapy versus levodopa/benserazide monotherapy in the treatment of Parkinson's disease: a systematic review and meta-analysis. Jiang DQ; Zang QM; Jiang LL; Wang Y; Li MX; Qiao JY Naunyn Schmiedebergs Arch Pharmacol; 2021 Sep; 394(9):1893-1905. PubMed ID: 33959780 [TBL] [Abstract][Full Text] [Related]
74. Comparison of selegiline and levodopa combination therapy versus levodopa monotherapy in the treatment of Parkinson's disease: a meta-analysis. Jiang DQ; Li MX; Jiang LL; Chen XB; Zhou XW Aging Clin Exp Res; 2020 May; 32(5):769-779. PubMed ID: 31175606 [TBL] [Abstract][Full Text] [Related]
75. Levodopa and the progression of Parkinson's disease. Fahn S; Oakes D; Shoulson I; Kieburtz K; Rudolph A; Lang A; Olanow CW; Tanner C; Marek K; N Engl J Med; 2004 Dec; 351(24):2498-508. PubMed ID: 15590952 [TBL] [Abstract][Full Text] [Related]
76. Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial. NINDS Exploratory Trials in Parkinson Disease (NET-PD) FS-ZONE Investigators Lancet Neurol; 2015 Aug; 14(8):795-803. PubMed ID: 26116315 [TBL] [Abstract][Full Text] [Related]
77. Comparative efficacy of selegiline versus rasagiline in the treatment of early Parkinson's disease. Marconi S; Zwingers T Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1879-82. PubMed ID: 25010617 [TBL] [Abstract][Full Text] [Related]
78. Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: a 6-month, randomized, placebo-controlled study. Ziegler M; Castro-Caldas A; Del Signore S; Rascol O Mov Disord; 2003 Apr; 18(4):418-25. PubMed ID: 12671949 [TBL] [Abstract][Full Text] [Related]
79. Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease. Hauser RA; Lew MF; Hurtig HI; Ondo WG; Wojcieszek J; Fitzer-Attas CJ; Mov Disord; 2009 Mar; 24(4):564-73. PubMed ID: 19086083 [TBL] [Abstract][Full Text] [Related]
80. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease. Parkinson Study Group CALM Cohort Investigators Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]